In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Novocure enters $150mm loan financing; pays off existing debt

Executive Summary

Novocure Ltd. (developed the Tumor Treating Fields alternating electrical field technology to treat cancer) entered into a $150mm non-dilutive term loan with BioPharma Credit PLC (managed by Pharmakon Advisors). The company drew down the loan in full immediately, and will use the proceeds to repay obligations under a 2015 $100mm loan agreement with Pharmakon's BioPharma Secured Investments
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Nonconvertible Debt
    • Private Placement

Related Companies

UsernamePublicRestriction

Register